Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Erratum: Effectiveness of Polypill for Prevention of Cardiovascular Disease (Polypars): Protocol of a Randomized Controlled Trial (Archives of Iranian Medicine (2020) 23:8 (548-556) Doi: 10.34172/Aim.2020.58) Publisher Pubmed



Malekzadeh F1, 2, 3 ; Gandomkar A2 ; Malekzadeh Z1 ; Poustchi H1, 4 ; Moghadami M2 ; Fattahi MR5 ; Moini M5 ; Anushiravani A1, 2 ; Mortazavi R6 ; Boogar SS6 ; Mohammadkarimi V6 ; Abtahi F7 ; Merat S1, 8 ; Sepanlou SG1 Show All Authors
Authors
  1. Malekzadeh F1, 2, 3
  2. Gandomkar A2
  3. Malekzadeh Z1
  4. Poustchi H1, 4
  5. Moghadami M2
  6. Fattahi MR5
  7. Moini M5
  8. Anushiravani A1, 2
  9. Mortazavi R6
  10. Boogar SS6
  11. Mohammadkarimi V6
  12. Abtahi F7
  13. Merat S1, 8
  14. Sepanlou SG1
  15. Malekzadeh R1, 2, 4, 8

Source: Archives of Iranian Medicine Published:2021


Abstract

This corrects the article “Effectiveness of polypill for prevention of cardiovascular disease (PolyPars): protocol of a randomized controlled trial” published on 2020: Volume 23, Issue 08, Pages 548-556. Correction to: Arch Iran Med. 2020;23(8):548-556. doi: 10.34172/aim.2020.58. In the original version of this article, the recruitment period was wrongly reported to last from December 2014 to December 2015 in abstract and methods sections of the article. This is corrected into “from December 2015 to December 2016” in the PDF and HTML versions of the article. Also the “PolyIran” is changed to “PolyPars” in the last paragraph of the discussion section in the PDF and HTML versions of the article. © 2021 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Other Related Docs